Literature DB >> 3316504

CT computerised stereotactic biopsy for low density CT lesions presenting with epilepsy.

J N Wilden1, P J Kelly.   

Abstract

Thirty five patients presenting with epilepsy alone and non-enhancing low-density lesion on the CT scan underwent a computer-assisted CT-guided stereotactic biopsy with stereotactic angiographic control. There was no mortality or morbidity in this series and the diagnostic yield was 97%. Thirty four patients had low grade intra-axial neoplasms. After an estimation of the pathological extent of the tumour, three patients underwent a computer-assisted stereotactic laser resection and 28 patients had radiotherapy.

Entities:  

Mesh:

Year:  1987        PMID: 3316504      PMCID: PMC1032455          DOI: 10.1136/jnnp.50.10.1302

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  12 in total

1.  The role of radiation therapy in the treatment of astrocytomas.

Authors:  S A Leibel; G E Sheline; W M Wara; E B Boldrey; S L Nielsen
Journal:  Cancer       Date:  1975-06       Impact factor: 6.860

2.  Treatment of grades I and II brain astrocytomas. The role of radiotherapy.

Authors:  J T Fazekas
Journal:  Int J Radiat Oncol Biol Phys       Date:  1977 Jul-Aug       Impact factor: 7.038

3.  Computer-assisted stereotaxis: new approaches for the management of intracranial intra-axial tumors.

Authors:  P J Kelly
Journal:  Neurology       Date:  1986-04       Impact factor: 9.910

4.  Stereotactic exploration of the brain in the era of computed tomography.

Authors:  L D Lunsford; A J Martinez
Journal:  Surg Neurol       Date:  1984-09

5.  Method of computed tomography-based stereotactic biopsy with arteriographic control.

Authors:  P J Kelly; G J Alker; B A Kall; S Goerss
Journal:  Neurosurgery       Date:  1984-02       Impact factor: 4.654

6.  A computed tomographic stereotactic adaptation system.

Authors:  S Goerss; P J Kelly; B Kall; G J Alker
Journal:  Neurosurgery       Date:  1982-03       Impact factor: 4.654

7.  Closed needle biopsy in the diagnosis of intracranial mass lesions.

Authors:  A G Shetter; T V Bertuccini; H W Pittman
Journal:  Surg Neurol       Date:  1977-11

8.  Morphologic evaluation of stereotactic brain tumour biopsies.

Authors:  P Kleihues; B Volk; J Anagnostopoulos; M Kiessling
Journal:  Acta Neurochir Suppl (Wien)       Date:  1984

9.  Stereotactic biopsy of brain tumors.

Authors:  C B Ostertag; H D Mennel; M Kiessling
Journal:  Surg Neurol       Date:  1980-10

10.  Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres.

Authors:  E R Laws; W F Taylor; M B Clifton; H Okazaki
Journal:  J Neurosurg       Date:  1984-10       Impact factor: 5.115

View more
  5 in total

1.  The prognosis of primary intracerebral tumours presenting with epilepsy: the outcome of medical and surgical management.

Authors:  J N Wilden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

2.  Proceedings of the joint meeting of the Society of British Neurological Surgeons (112th meeting), the Neurosurgical Society of Australia and the Neuroanaesthetists Travelling Club. Oxford, 14-15 April, 1988. Abstracts.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

3.  Focal epilepsy in India.

Authors:  P G Divate; C A Apte
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-10       Impact factor: 10.154

4.  Hippocampal neuronal density in temporal lobe epilepsy with and without gliomas.

Authors:  J H Kim; P O Guimaraes; M Y Shen; L M Masukawa; D D Spencer
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 5.  The role of neuropathology in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Authors:  Daniel P Cahill; Andrew E Sloan; Brian V Nahed; Kenneth D Aldape; David N Louis; Timothy C Ryken; Steven N Kalkanis; Jeffrey J Olson
Journal:  J Neurooncol       Date:  2015-11-03       Impact factor: 4.130

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.